Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Vanderbilt-Ingram Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00712556 |
RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 PET scans, may help doctors predict a patient's response to treatment and help plan the best treatment.
PURPOSE: This phase I trial is studying fludeoxyglucose F 18 PET scan to see how well it predicts outcomes in patients who have undergone high-dose chemotherapy and autologous stem cell transplant for non-Hodgkin lymphoma.
Condition | Intervention | Phase |
---|---|---|
Lymphoma |
Radiation: fludeoxyglucose F 18 |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label |
Official Title: | Positron Emission Tomography Study in Patients With Non-Hodgkin Lymphoma |
Estimated Enrollment: | 63 |
Study Start Date: | May 2008 |
Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Conventional imaging, biopsy, and clinical examination findings are reviewed to determine patient clinical outcome (e.g., complete response, disease progression/relapse, or death related to the primary disease).
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Has undergone high-dose chemotherapy followed by autologous stem cell transplantation at Vanderbilt University between March 1997 and August 2005
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Tennessee | |
Vanderbilt-Ingram Cancer Center - Cool Springs | |
Nashville, Tennessee, United States, 37064 | |
Vanderbilt-Ingram Cancer Center at Franklin | |
Nashville, Tennessee, United States, 37064 | |
Vanderbilt-Ingram Cancer Center | |
Nashville, Tennessee, United States, 37232-6838 |
Principal Investigator: | Adetola A. Kassim, MD | Vanderbilt-Ingram Cancer Center |
Study ID Numbers: | CDR0000596047, VU-VICC-BMT-0828, VU-VICC-080426 |
Study First Received: | July 9, 2008 |
Last Updated: | March 14, 2009 |
ClinicalTrials.gov Identifier: | NCT00712556 History of Changes |
Health Authority: | United States: Federal Government |
stage III adult Burkitt lymphoma stage III adult diffuse large cell lymphoma stage III adult diffuse mixed cell lymphoma stage III adult diffuse small cleaved cell lymphoma stage III adult immunoblastic large cell lymphoma stage III adult lymphoblastic lymphoma stage III grade 1 follicular lymphoma stage III grade 2 follicular lymphoma stage III grade 3 follicular lymphoma stage III mantle cell lymphoma stage III marginal zone lymphoma stage III small lymphocytic lymphoma stage IV adult Burkitt lymphoma stage IV adult diffuse large cell lymphoma stage IV adult diffuse mixed cell lymphoma |
stage IV adult diffuse small cleaved cell lymphoma stage IV adult immunoblastic large cell lymphoma stage IV adult lymphoblastic lymphoma stage IV grade 1 follicular lymphoma stage IV grade 2 follicular lymphoma stage IV grade 3 follicular lymphoma stage IV mantle cell lymphoma stage IV marginal zone lymphoma stage IV small lymphocytic lymphoma recurrent adult Burkitt lymphoma recurrent adult diffuse large cell lymphoma recurrent adult diffuse mixed cell lymphoma recurrent adult diffuse small cleaved cell lymphoma recurrent adult immunoblastic large cell lymphoma recurrent adult lymphoblastic lymphoma |
Lymphoma, Mantle-Cell Lymphoma, Follicular Sezary Syndrome Lymphoma, B-Cell, Marginal Zone Mantle Cell Lymphoma Mycosis Fungoides Lymphoblastic Lymphoma Follicular Lymphoma Lymphoma, Large-cell, Immunoblastic Lymphoma, B-Cell Lymphoma, Small Cleaved-cell, Diffuse Mycoses Cutaneous T-cell Lymphoma Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, T-Cell |
Lymphoma, Large-Cell, Immunoblastic Lymphoma, Large-cell Leukemia, B-cell, Chronic Lymphoma Lymphoma, Large B-Cell, Diffuse Immunoproliferative Disorders Small Non-cleaved Cell Lymphoma Recurrence Burkitt's Lymphoma Lymphatic Diseases Chronic Lymphocytic Leukemia B-cell Lymphomas Burkitt Lymphoma Lymphoma, Non-Hodgkin Lymphoproliferative Disorders |
Lymphatic Diseases Neoplasms Immunoproliferative Disorders Neoplasms by Histologic Type Immune System Diseases |
Lymphoma, Large-Cell, Immunoblastic Lymphoproliferative Disorders Lymphoma, Non-Hodgkin Lymphoma |